首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >ARF mutation accelerates pituitary tumor development in Rb+/- mice
【24h】

ARF mutation accelerates pituitary tumor development in Rb+/- mice

机译:ARF突变可加速Rb +/-小鼠的垂体瘤发展

获取原文
获取原文并翻译 | 示例
           

摘要

Mice heterozygous for the retinoblastoma (Rb) tumor suppressor gene develop pituitary and thyroid tumors with high penetrance. We demonstrate here that loss of the ARF tumor suppressor strongly accelerates intermediate lobe pituitary tumorigenesis in Rb heterozygous mice. These effects in the pituitary are greater than those conferred by pS3 loss in that Rb+/-; ARF-/- mice display significantly more early atypical lesions than Rb+/-; p53-/- mice. Also, Rb+/-; ARF- /- compound mutants do not develop many of the novel tumors or precancerous lesions seen in Rb+/-;p53-/- compound mutants. Although complete loss of ARF expression is not obligatory for pituitary tumorigenesis in Rb+/- mice, alterations of the ARF locus are observed in tumors from Rb+/-; ARF+/- mice, consistent with a selective advantage of ARF inactivation in this context. We conclude that inacti-vation of ARF acts more broadly than that of p53 in connecting abrogation of the Rb pathway to tumorigenesis.
机译:视网膜母细胞瘤(Rb)肿瘤抑制基因的杂合小鼠会发展出高穿透性的垂体和甲状腺肿瘤。我们在这里证明,ARF肿瘤抑制因子的丧失强烈地加速了Rb杂合小鼠的中间叶垂体垂体肿瘤发生。在垂体中的这些作用大于在Rb +/-中pS3丧失所引起的作用。 ARF-/-小鼠显示出比Rb +/-明显更多的早期非典型病变。 p53-/-小鼠。另外,Rb +/-;在Rb +/-; p53-/-复合突变体中,ARF-/-复合突变体不会发展出许多新型肿瘤或癌前病变。尽管Rb +/-小鼠的垂体肿瘤发生不一定要完全丧失ARF表达,但在Rb +/-的肿瘤中观察到了ARF基因座的改变。 ARF +/-小鼠,在这种情况下与ARF灭活的选择性优势一致。我们得出结论,在将Rb途径废止与肿瘤发生联系起来的过程中,ARF的失活作用比p53的作用更广泛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号